Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp, based in Sherborn, MA, is a clinical-stage biopharmaceutical company co-founded by Nobel Prize scientist Craig Mello, who is renowned for his discovery of RNA interference (RNAi). The company leverages this legacy to advance innovative RNA therapies, particularly focusing on its proprietary INTASYL siRNA technology to enhance the effectiveness of immune cells in targeting and killing cancer cells.
Phio is dedicated to developing treatments for cutaneous squamous cell carcinoma (SCC) and melanoma, positioning itself at the forefront of immuno-oncology. With new leadership in place, the company is transitioning from discovery to development, aiming to make significant strides in the fight against cancer.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.